" class="no-js "lang="en-US"> VeriFLY ™ Now First Digital Wallet To Accept Vaccine Health Credential Around The World - Medtech Alert
Thursday, December 05, 2024

VeriFLY ™ Now First Digital Wallet To Accept Vaccine Health Credential Around The World

VeriFLY ™, the world’s first widely adopted digital wallet created to help travelers and event attendees quickly and safely meet their destination’s COVID-19 requirements, is now offering the ability to upload vaccination cards as part of their secure digital health credentials.

“VeriFLY is committed to establishing digital interfaces to global sources of verifiable clinical information, including proof of vaccines, as they become available,” said Daon CEO Tom Grissen. “To ensure the equitable inclusion of all travelers in meeting their current COVID-19 requirements, VeriFLY is immediately offering the ability to upload vaccination cards as part of their secure digital health credentials to ensure a digital divide does not exacerbate health inequities.”

The VeriFLY app continues to grow in popularity around the world. Now with more than 800,000 active users departing from more than 60 countries on six continents, VeriFLY provides clear information in one place that customers and governments can trust. It enables customers to complete all travel requirements in one simple app while securing data and safeguarding confidential information.

“We are gratified that travelers and event attendees around the world have turned to VeriFLY to assist in their life journeys as we begin to see a return to normalcy,” Grissen added. “The VeriFLY app will help not only with air travel, but also at conventions, sporting events and concerts. We envision a world where your VeriFLY digital wallet will provide access to the places you and your family want to visit. And the ability to accept a vaccine health credential will accelerate opportunities to resume activities we’ve all dearly missed.”

American Airlines – the first airline to offer VeriFLY to its customers – will provide travelers the option to use the VeriFLY app to securely upload their vaccine documentation for travel to El Salvador, Guatemala and the Bahamas. Travelers can simply upload a photo of both sides of their COVID-19 vaccine record into the app. The VeriFLY team will review that all documentation meets the destination requirements.

Julie Rath, Vice President of Customer Experience at American Airlines, added that VeriFLY gives customers peace of mind that they can meet their destination’s travel requirements and save them significant time at the airport. As countries reopen to those who have been vaccinated, American Airlines will be ready with VeriFLY to help their customers travel with confidence.

Grissen noted that Daon has trained professionals that can analyze vaccination cards prior to a customer arriving at the airport, giving them a streamlined travel experience.

“Daon’s design team is using digital comparative analysis in combination with human review to help guard against the use of fraudulent documents,” Grissen added. “As more and more travelers upload vaccination cards and test results our algorithms will only get more accurate and effective. We believe we can train our algorithms to help combat fraud at scale, however, the ultimate goal should be for government and other parties to come together and create sources of verifiable credentials. As an industry leader for more than 20 years, we feel Daon can play a role in bringing these parties together.”

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more